Trials / Unknown
UnknownNCT00558597
Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
In patients with acute rejection after lung transplantation the peptide profile in broncho-alveolar lavage (BAL) and urine should be compared in order to identify a paradigm that allows an non-invasive rejection therapy.
Detailed description
Goal of the study is the establishment of biomarkers for early diagnosis of acute rejection, followed by a late validation of the paradigm with prospectively collected samples, which will be examined blinded.
Conditions
Timeline
- Start date
- 2008-03-01
- Completion
- 2011-12-01
- First posted
- 2007-11-15
- Last updated
- 2011-07-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00558597. Inclusion in this directory is not an endorsement.